Ten years after learning their polygenic risk score, patients had fewer events—perhaps due to greater use of statin therapy.

Statins have been used safely for years. They help to lower LDL-C "bad" cholesterol by reducing the production of it by the ...

Not everyone is sold on the benefits of early ezetimibe use, especially given the modest effect seen in IMPROVE-IT.

The lipophilic statin group had slightly better outcomes than ... using statins helped to decrease the risk for hepatocellular carcinoma by 57%. Statin-using participants with cirrhosis saw ...

including whether a statin was recommended based on a high-risk score. Patients in the two groups in the study were found to have very similar baseline characteristics. However, researchers found ...

Patients who used statins had a reduced risk for HCC, hepatic decompensation and fibrosis progression. Lipophilic statin use and longer duration of exposure were associated with even greater ...

Statin therapy significantly reduced the risk of all CVEs (RR 0.83; 95% CI 0.76 to 0.91) and the risk of ischemic stroke (RR 0.79; 95% CI 0.63 to 0.99). Statin therapy did not significantly reduce ...

A new study found that adding a second drug early after a heart attack may save lives. Those who added ezetimibe to a statin ...

As inflammation and oxidative stress occur in depression, there is interest in their potential to reduce depression risk. We investigated whether use of statin medications was associated with a ...